Welcome to the inaugural issue of our new publication, Cannabis Science and Technology. We are thrilled that our group is a part of the cutting edge in cannabis science and will help unveil what the future holds for this industry. In alliance with the Cannabis Science Conference, this new professional journal and website will focus on educating the legal cannabis industry about the science and technology of analytical testing and quality control, including topics such as
With our portfolio of leading science and pharmaceutical brands, including LCGC, Spectroscopy, Nutritional Outlook, PharmTech, and BioPharm International, we have extensive experience keeping readers in fields such as analytical chemistry, pharmaceutical development and manufacturing, and nutritional supplements informed about the latest techniques, best practices, and regulatory information. Given the knowledge and experience we have from producing those thought-provoking and industry-relevant brands, launching Cannabis Science and Technology is a perfect next step into the future of analytical science. This new publication will mirror the quality of content and circulation that makes our other publications so successful.
The recent acceleration in the acceptance of cannabis as a valuable medical treatment places the industry at a critical juncture. With the launch of Cannabis Science and Technology, we are taking an important step to connect the scientific community we serve with the fast-growing cannabis industry.
Cannabis Science and Technology will be published quarterly in 2018 and will appear at all the major trade shows this year. Be sure to pick up a copy of our latest issue at the next show near you, or visit our website, www.cannabissciencetech.com, for the latest information on subscriptions, newsletters, articles, and more.
Michael J. Tessalone is the Vice President and Stephanie Shaffer is the publisher of Cannabis Science Technology. Direct correspondence to: stephanie.shaffer@ubm.com
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.